In The News

Ropes & Gray Guides StemCells, Inc. in Asset Purchase Agreement for Stem and Progenitor Cell Lines

Practices: China Life Sciences, Life Sciences, Securities & Public Companies

Ropes & Gray advised StemCells, Inc., a California based developer of stem cell based therapeutic technologies, on the sale of its proprietary human neural stem cell technology platform to BOCO Silicon Valley, an affiliate of Bright Oceans Corporation, a China-based conglomerate. The transaction was structured as an asset sale and was consummated in connection with the merger of StemCells with Microbot Medical.

The Ropes & Gray team was led by life sciences partner Arthur Mok (Shanghai) and included securities & public companies partner Marko Zatylny (Boston).

Cookie Settings